Peptide research advances antiviral therapies and endocrine signaling

Research into peptides is expanding across multiple medical fields, specifically regarding antiviral efficacy and endocrine signaling. In antiviral applications, peptides are being studied for their ability to enhance immune responses, inhibit viral entry into host cells, and target critical viral enzymes to reduce viral loads. Studies have explored their potential in treating HIV, influenza, and hepatitis C.

In the field of endocrine signaling, researchers are examining the synergistic effects of combining Sermorelin and GHRP-2. Sermorelin acts as a synthetic analog of growth hormone-releasing hormone (GHRH) to influence the anterior pituitary, while GHRP-2 interacts with the growth hormone secretagogue receptor (GHS-R). The dual-pathway approach suggests these peptides may activate different intracellular signaling routes, potentially offering complementary mechanisms for modulating growth hormone dynamics.